Pricing

Intellipharmaceutics International Inc (IPCIF)

followers ·
Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Isa Odidi
Employees:
10
30 WORCESTER ROAD, TORONTO, A6, M9W 5X2
416-798-3001
Stock Split History
DateRatio
2018-09-14 1:10
Intellipharmaceutics International Inc. researches, develops, and manufactures novel and generic controlled-release and targeted-release oral solid dosage drugs in the United States. The company offers Focalin XR, a dexmethylphenidate hydrochloride extended-release capsule for hyperactivity disorder. Keppra XR is a levetiracetam extended release tablet for the treatment of partial onset seizures in patients with epilepsy. Protonix is a pantoprazole sodium delayed-release tablet to treat gastroesophageal reflux disease.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available